Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notice Inventory
  • Print
  • Share
  • E-mail
-
 

GRN No. 41


Martek Biosciences Corporation
6480 Dobbin Road; Columbia, MD 21045
 
Return to Listing
 
Substance:  DHASCO (docosahexaenoic acid-rich single-cell oil) and ARASCO (arachidonic acid-rich single-cell oil)
 
Intended Use:  Provide DHASCO (as a source of docosahexaenoic acid) and ARASCO (as a source of arachidonic acid) in term infant formula, at a maximum level of 1.25 percent each of the total dietary fat and at a ratio ranging from 1:1 to 1:2 (DHASCO:ARASCO)
 
Basis:  Scientific procedures
 
Date of filing:  01-MAR-00
 
Date of closure (select to view letter):  17-MAY-01
 
GRAS Notice (disclosable information):  GRN 41
-
-